Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03367819
Title Isatuximab in Combination With REGN2810 in Patients With Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sanofi
Indications

lung non-small cell carcinoma

prostate cancer

Therapies

Isatuximab

Cemiplimab + Isatuximab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA


No variant requirements are available.